AN2 Therapeutics, Inc. financial statements
AN2 Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 35.17M | 10-K |
| Cash and equivalents | USD 19.94M | 10-Q |
AN2 Therapeutics, Inc. financials on 6ix · AN2 Therapeutics, Inc. on 6ix